Compare AOD & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | AOD | YDES |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United Kingdom | Taiwan |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 970.0M | 1.1B |
| IPO Year | N/A | N/A |
| Metric | AOD | YDES |
|---|---|---|
| Price | $9.62 | $13.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 423.5K | 87.4K |
| Earning Date | 01-01-0001 | 09-30-2025 |
| Dividend Yield | ★ 12.95% | N/A |
| EPS Growth | ★ 213.63 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $72,962,082.00 | $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.44 | ★ N/A |
| Revenue Growth | N/A | ★ 45.76 |
| 52 Week Low | $6.99 | $5.30 |
| 52 Week High | $9.14 | $31.00 |
| Indicator | AOD | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | N/A |
| Support Level | $9.19 | N/A |
| Resistance Level | $9.67 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 89.69 | 0.00 |
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.